IS8220A - Bensímídasólafleiður, blöndur sem innihalda þær, framleiðsla þeirra og notkun - Google Patents
Bensímídasólafleiður, blöndur sem innihalda þær, framleiðsla þeirra og notkunInfo
- Publication number
- IS8220A IS8220A IS8220A IS8220A IS8220A IS 8220 A IS8220 A IS 8220A IS 8220 A IS8220 A IS 8220A IS 8220 A IS8220 A IS 8220A IS 8220 A IS8220 A IS 8220A
- Authority
- IS
- Iceland
- Prior art keywords
- preparation
- mixtures containing
- benzimidazole derivatives
- benzimidazole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Oncology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0301699A SE0301699D0 (sv) | 2003-06-10 | 2003-06-10 | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
PCT/GB2004/002427 WO2004108688A1 (en) | 2003-06-10 | 2004-06-09 | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IS8220A true IS8220A (is) | 2006-01-04 |
Family
ID=29212433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS8220A IS8220A (is) | 2003-06-10 | 2006-01-04 | Bensímídasólafleiður, blöndur sem innihalda þær, framleiðsla þeirra og notkun |
Country Status (24)
Country | Link |
---|---|
US (1) | US7517898B2 (is) |
EP (1) | EP1636193A1 (is) |
JP (1) | JP2006527247A (is) |
KR (1) | KR20060017863A (is) |
CN (2) | CN101328151A (is) |
AR (1) | AR044665A1 (is) |
AU (1) | AU2004245296B2 (is) |
BR (1) | BRPI0411226A (is) |
CA (1) | CA2528924A1 (is) |
CO (1) | CO5660261A2 (is) |
IL (1) | IL172027A0 (is) |
IS (1) | IS8220A (is) |
MX (1) | MXPA05013050A (is) |
MY (1) | MY139676A (is) |
NO (1) | NO20060146L (is) |
NZ (1) | NZ543632A (is) |
RU (1) | RU2329254C2 (is) |
SA (1) | SA04250161B1 (is) |
SE (1) | SE0301699D0 (is) |
TW (1) | TW200504030A (is) |
UA (1) | UA83832C2 (is) |
UY (1) | UY28357A1 (is) |
WO (1) | WO2004108688A1 (is) |
ZA (1) | ZA200509869B (is) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0302573D0 (sv) * | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
SE0302570D0 (sv) * | 2003-09-26 | 2003-09-26 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
RU2374234C2 (ru) | 2004-09-24 | 2009-11-27 | Астразенека Аб | Бензимидазольные производные, содержащие их композиции, их получение и применение |
EP1912930A4 (en) * | 2005-07-29 | 2010-04-14 | Astrazeneca Ab | PROCESS FOR PREPARING GEMINAL ((DIFLUORCYCLOALKYL) METHYL) AMINE |
JP5157892B2 (ja) | 2006-02-20 | 2013-03-06 | アステラス製薬株式会社 | アミド誘導体またはその塩 |
TW200745049A (en) | 2006-03-23 | 2007-12-16 | Astrazeneca Ab | New crystalline forms |
TW200808769A (en) * | 2006-04-18 | 2008-02-16 | Astrazeneca Ab | Therapeutic compounds |
TW200808772A (en) * | 2006-06-13 | 2008-02-16 | Astrazeneca Ab | Therapeutic compounds |
US20080139846A1 (en) * | 2006-09-01 | 2008-06-12 | Astrazeneca Ab | New Process 298 |
WO2008153701A1 (en) * | 2007-05-24 | 2008-12-18 | Schering Corporation | Compounds for inhibiting ksp kinesin activity |
EP2234487A4 (en) * | 2007-12-19 | 2011-09-07 | Scripps Research Inst | ANILIDES AND ANALOGUES AS INHIBITORS OF RHO KINASE |
US20110086853A1 (en) * | 2009-10-08 | 2011-04-14 | William Brown | Therapeutic Compounds |
ME02663B (me) * | 2010-10-06 | 2017-06-20 | Glaxosmithkline Llc | Derivati benzimidazola kao inhibitori pi3 kinaze |
PL2897939T3 (pl) * | 2012-09-21 | 2017-08-31 | Sanofi | Pochodne amidu kwasu benzoimidazolo-karboksylowego do leczenia chorób metabolicznych i sercowo-naczyniowych |
SG11201707418WA (en) | 2015-03-13 | 2017-10-30 | Forma Therapeutics Inc | Alpha-cinnamide compounds and compositions as hdac8 inhibitors |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9121776D0 (en) * | 1991-10-14 | 1991-11-27 | Fujisawa Pharmaceutical Co | Benzimidazole derivatives and process for preparation thereof |
JP3295277B2 (ja) * | 1994-06-01 | 2002-06-24 | 呉羽化学工業株式会社 | 抗腎疾患剤及びベンズイミダゾール誘導体 |
TR199801249T2 (xx) * | 1995-12-28 | 1998-10-21 | Fujisawa Pharmaceutical Co,Ltd. | Benzimidazol t�revleri. |
US6348032B1 (en) * | 1998-11-23 | 2002-02-19 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with benzimidazole derivatives |
FR2789079B3 (fr) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
JP2001247550A (ja) * | 1999-12-27 | 2001-09-11 | Japan Tobacco Inc | 縮合環化合物及びその医薬用途 |
PA8535601A1 (es) * | 2000-12-21 | 2002-11-28 | Pfizer | Derivados benzimidazol y piridilimidazol como ligandos para gabaa |
SE0101387D0 (sv) * | 2001-04-20 | 2001-04-20 | Astrazeneca Ab | Novel compounds |
US7196095B2 (en) * | 2001-06-25 | 2007-03-27 | Merck & Co., Inc. | (Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds |
TWI231757B (en) * | 2001-09-21 | 2005-05-01 | Solvay Pharm Bv | 1H-Imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activity |
WO2003053938A1 (en) * | 2001-12-20 | 2003-07-03 | Novo Nordisk A/S | Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten |
SE0203070D0 (en) * | 2002-10-16 | 2002-10-16 | Astrazeneca Ab | Novel compounds |
SE0301698D0 (sv) * | 2003-06-10 | 2003-06-10 | Astrazeneca Ab | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
-
2003
- 2003-06-10 SE SE0301699A patent/SE0301699D0/xx unknown
-
2004
- 2004-06-08 MY MYPI20042197A patent/MY139676A/en unknown
- 2004-06-09 BR BRPI0411226-1A patent/BRPI0411226A/pt not_active IP Right Cessation
- 2004-06-09 RU RU2005138371/04A patent/RU2329254C2/ru not_active IP Right Cessation
- 2004-06-09 KR KR1020057023712A patent/KR20060017863A/ko not_active Application Discontinuation
- 2004-06-09 EP EP04736410A patent/EP1636193A1/en not_active Withdrawn
- 2004-06-09 CN CNA2008101360526A patent/CN101328151A/zh active Pending
- 2004-06-09 CA CA002528924A patent/CA2528924A1/en not_active Abandoned
- 2004-06-09 WO PCT/GB2004/002427 patent/WO2004108688A1/en active Application Filing
- 2004-06-09 US US10/557,813 patent/US7517898B2/en not_active Expired - Fee Related
- 2004-06-09 MX MXPA05013050A patent/MXPA05013050A/es active IP Right Grant
- 2004-06-09 AU AU2004245296A patent/AU2004245296B2/en not_active Ceased
- 2004-06-09 NZ NZ543632A patent/NZ543632A/xx unknown
- 2004-06-09 JP JP2006516384A patent/JP2006527247A/ja active Pending
- 2004-06-09 CN CNA2004800163272A patent/CN1805940A/zh active Pending
- 2004-06-10 UY UY28357A patent/UY28357A1/es unknown
- 2004-06-10 AR ARP040102016A patent/AR044665A1/es not_active Application Discontinuation
- 2004-06-10 TW TW093116702A patent/TW200504030A/zh unknown
- 2004-06-12 SA SA04250161A patent/SA04250161B1/ar unknown
- 2004-09-06 UA UAA200511189A patent/UA83832C2/ru unknown
-
2005
- 2005-11-17 IL IL172027A patent/IL172027A0/en unknown
- 2005-12-05 CO CO05123385A patent/CO5660261A2/es not_active Application Discontinuation
- 2005-12-05 ZA ZA200509869A patent/ZA200509869B/xx unknown
-
2006
- 2006-01-04 IS IS8220A patent/IS8220A/is unknown
- 2006-01-10 NO NO20060146A patent/NO20060146L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2329254C2 (ru) | 2008-07-20 |
CO5660261A2 (es) | 2006-07-31 |
BRPI0411226A (pt) | 2006-07-18 |
CA2528924A1 (en) | 2004-12-16 |
NZ543632A (en) | 2009-02-28 |
US20070060583A1 (en) | 2007-03-15 |
KR20060017863A (ko) | 2006-02-27 |
ZA200509869B (en) | 2006-11-29 |
AR044665A1 (es) | 2005-09-21 |
UA83832C2 (ru) | 2008-08-26 |
AU2004245296B2 (en) | 2008-05-22 |
JP2006527247A (ja) | 2006-11-30 |
EP1636193A1 (en) | 2006-03-22 |
CN1805940A (zh) | 2006-07-19 |
NO20060146L (no) | 2006-03-07 |
AU2004245296A1 (en) | 2004-12-16 |
US7517898B2 (en) | 2009-04-14 |
CN101328151A (zh) | 2008-12-24 |
WO2004108688A1 (en) | 2004-12-16 |
SE0301699D0 (sv) | 2003-06-10 |
UY28357A1 (es) | 2005-01-31 |
MY139676A (en) | 2009-10-30 |
SA04250161B1 (ar) | 2009-04-18 |
MXPA05013050A (es) | 2006-03-02 |
RU2005138371A (ru) | 2006-07-27 |
IL172027A0 (en) | 2011-08-01 |
TW200504030A (en) | 2005-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS8220A (is) | Bensímídasólafleiður, blöndur sem innihalda þær, framleiðsla þeirra og notkun | |
IS8422A (is) | Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun þeirra | |
IS8219A (is) | Bensímídasólafleiður, efnablöndur sem innihalda þær, framleiðsla þeirra og notkun | |
DK1673349T3 (da) | Benzimidazolderivater: fremstilling og farmaceutiske anvendelser | |
NO20053974D0 (no) | Tienopyrimidinforbindelser og anvendelse derav. | |
NO20055026D0 (no) | Indolonacetamid-derivater, fremgangsmate for fremstilling og anvendelse av disse | |
IS2529B (is) | Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar | |
HK1085735A1 (en) | New benzimidazole derivatives | |
NO20055568D0 (no) | Substituerte 1,4-diazepiner og anvendelser derav | |
IS7376A (is) | N-arýl-2-oxasólidínón-5-karboxamið og afleiður þeirra og notkun þeirra sem bakteríueyðandi efni | |
IS2458B (is) | Indólín-2-ón afleiður, framleiðsla og notkun þeirra sem mjaltavaka (ocytocin) viðtakabindlar | |
IS7491A (is) | Benzoxazínon-afleidd efnasambönd, framleiðsla þeirra og notkun sem lyf | |
IS6661A (is) | Bensimídasólafleiður, framleiðsla þeirra og meðferðarleg notkun | |
NO20053809D0 (no) | Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav | |
PL1694649T3 (pl) | Pochodne 2-pirydynyloetylokarboksyamidu i ich zastosowanie jako fungicydów | |
DK1590321T3 (da) | Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf | |
DK1513836T3 (da) | Piperazinylacylpiperidinderivater, fremstilling og terapeutisk anvendelse heraf | |
DK1773829T3 (da) | Aminotropanderivater, fremstilling og terapeutiske anvendelser heraf | |
IL181683A0 (en) | Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof | |
DK1334106T3 (da) | Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf | |
DK1556382T3 (da) | 3-Phenylpyridoindolderivater, fremstilling og terapeutisk anvendelse deraf | |
IS7694A (is) | Sterasamrunaefnasambönd, framleiðsla og notkun þeirra | |
DK1940840T3 (da) | 6-heteroarylpyridoindolon-derivater, fremstilling deraf og terapeutisk anvendelse deraf | |
NO20052356D0 (no) | Redningsskoyte | |
NO20053805D0 (no) | Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav |